These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Carcinoembryonic antigen in gynecologic patients. II. Immunohistological expression. Fenoglio CM, Crum CP, Pascal RR, Richart RM. Diagn Gynecol Obstet; 1981 Sep; 3(4):291-9. PubMed ID: 7338157 [Abstract] [Full Text] [Related]
5. [The value of CEA determination in gynecologic tumor patients (proceedings)]. Born HJ, Baumann R, Dericks-Tan JS. Arch Gynakol; 1977 Jul 29; 224(1-4):471-2. PubMed ID: 579914 [No Abstract] [Full Text] [Related]
6. [Diagnosis: tumor marker]. Inaba N, Takamizawa Y, Ota J, Fukazawa K. Gan No Rinsho; 1990 Aug 29; 36(10):1123-7. PubMed ID: 2214148 [Abstract] [Full Text] [Related]
11. [Significance of rectoromanoscopy during examination of gynecologic patients]. Ol'shanetskiĭ AS. Vopr Onkol; 1966 Aug 29; 12(11):81-3. PubMed ID: 6003521 [No Abstract] [Full Text] [Related]
12. Delays in diagnosis and stage of disease in gynecologic cancer. Fruchter RG, Boyce J. Cancer Detect Prev; 1981 Aug 29; 4(1-4):481-6. PubMed ID: 7349814 [No Abstract] [Full Text] [Related]
15. [Transvaginal echography in gynecologic oncology]. Besson P, Constant M, Besson-Proye F. Ann Radiol (Paris); 1989 Aug 29; 32(5):435-40. PubMed ID: 2692505 [Abstract] [Full Text] [Related]
16. Selective decrease in serum immunoglobulin G1. A tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiency. Schauenstein E, Lahousen M, Weblacher M, Steinschifter W, Estelberger W, Schauenstein K. Cancer; 1996 Aug 01; 78(3):511-6. PubMed ID: 8697398 [Abstract] [Full Text] [Related]